DK1094804T3 - Behandling af nyrekolik med GABA-analoger - Google Patents

Behandling af nyrekolik med GABA-analoger

Info

Publication number
DK1094804T3
DK1094804T3 DK99935443T DK99935443T DK1094804T3 DK 1094804 T3 DK1094804 T3 DK 1094804T3 DK 99935443 T DK99935443 T DK 99935443T DK 99935443 T DK99935443 T DK 99935443T DK 1094804 T3 DK1094804 T3 DK 1094804T3
Authority
DK
Denmark
Prior art keywords
treatment
renal colic
gaba analogues
gaba
analogues
Prior art date
Application number
DK99935443T
Other languages
English (en)
Inventor
James T Angello
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of DK1094804T3 publication Critical patent/DK1094804T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/04—Drugs for disorders of the urinary system for urolithiasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK99935443T 1998-07-09 1999-07-08 Behandling af nyrekolik med GABA-analoger DK1094804T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9216798P 1998-07-09 1998-07-09

Publications (1)

Publication Number Publication Date
DK1094804T3 true DK1094804T3 (da) 2006-02-06

Family

ID=22231960

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99935443T DK1094804T3 (da) 1998-07-09 1999-07-08 Behandling af nyrekolik med GABA-analoger

Country Status (16)

Country Link
EP (1) EP1094804B1 (da)
JP (1) JP2002520278A (da)
KR (1) KR20010071780A (da)
AT (1) ATE305778T1 (da)
AU (1) AU766708B2 (da)
BR (1) BR9911925A (da)
CA (1) CA2332931C (da)
DE (1) DE69927591T2 (da)
DK (1) DK1094804T3 (da)
ES (1) ES2249905T3 (da)
ID (1) ID29346A (da)
NO (1) NO20010115D0 (da)
NZ (1) NZ509230A (da)
PL (1) PL345953A1 (da)
WO (1) WO2000002547A2 (da)
ZA (1) ZA200007172B (da)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001876A (en) * 1996-07-24 1999-12-14 Warner-Lambert Company Isobutylgaba and its derivatives for the treatment of pain

Also Published As

Publication number Publication date
WO2000002547A3 (en) 2000-05-04
NO20010115L (no) 2001-01-08
EP1094804A2 (en) 2001-05-02
BR9911925A (pt) 2001-03-27
WO2000002547A2 (en) 2000-01-20
ID29346A (id) 2001-08-23
ZA200007172B (en) 2002-03-04
NZ509230A (en) 2003-08-29
ATE305778T1 (de) 2005-10-15
KR20010071780A (ko) 2001-07-31
DE69927591T2 (de) 2006-07-06
NO20010115D0 (no) 2001-01-08
EP1094804B1 (en) 2005-10-05
JP2002520278A (ja) 2002-07-09
AU5092299A (en) 2000-02-01
ES2249905T3 (es) 2006-04-01
PL345953A1 (en) 2002-01-14
AU766708B2 (en) 2003-10-23
DE69927591D1 (de) 2006-02-16
CA2332931A1 (en) 2000-01-20
CA2332931C (en) 2007-04-24

Similar Documents

Publication Publication Date Title
DK0934061T3 (da) Isobutylgaba og dets derivater til behandling af smerte
DK0840601T3 (da) THIP til behandling af søvnforstyrrelser
CA2333024A1 (en) Method for the treatment of insomnia
DK1009399T3 (da) GABA-analoger til forebyggelse og behandling af gastrointestinal skade
DE60119919D1 (de) Freie aminosäure enthaltende zusammensetzung
DK1121114T3 (da) Anvendelse af GABA-analoger til fremstilling af et medikament til behandling af mani og bipolære lidelser
EA200501497A1 (ru) АМИНОКИСЛОТЫ С АФФИННОСТЬЮ К α2β-БЕЛКУ
ATE493978T1 (de) Behandlung von autoimmunerkrankungen
DK0994704T3 (da) Anvendelse af GABA-analoger såsom gabapentin i fremstillingen af et medikament til behandling af inflammatoriske sygdomme
DE60044160D1 (de) Behandlung von Inkontinenz
DK1094804T3 (da) Behandling af nyrekolik med GABA-analoger
DK1093366T3 (da) Farmaceutisk sammensætning indeholdende GABA-analoge og et antivirusmiddel til behandling af helvedesild
DK0880971T3 (da) Markofagstimulerende protein til behandling af sygdomme i centralnervesystemet